NCT02159001

Electroconvulsive Therapy in Clozapine-resistant Schizophrenia

Efficacy and Cognitive Effects of Electroconvulsive Therapy in Clozapine-Resistant Schizophrenia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Niuvanniemi Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

Electroconvulsive therapy (ECT) is one of the oldest neuromodulation treatments still used in psychiatry. Only case reports and open label non-randomized studies have been published of ECT in clozapine-resistant schizophrenia patients. The purpose of this trial is to study the efficacy and cognitive effects of add-on ECT treatment (10-course) in schizophrenia patients taking clozapine.

Conditions

• Schizophrenia
• Schizoaffective Disorder

Interventions

Type	Name	Description
DEVICE	electroconvulsive therapy	10-course, three times a week bilateral frontotemporal ECT

Timeline

• Start date: 2014-06-01
• Primary completion: 2017-12-01
• Completion: 2018-06-01
• First posted: 2014-06-09
• Last updated: 2015-10-16

Locations

1 site across 1 country: Finland